‘Because there is more to do’
Welcome to ‘Because there is more to do’: the engagement initiative of Bristol Myers Squibb.
‘Because there is more to do’ is an initiative that began in late 2020. It’s an open invitation to people in 8 European countries to share their views.
We asked people for their opinion of BMS and pharmaceutical companies in general; what are their unmet needs; and what more they think pharma can do to help support patients along their treatment journeys and contribute to society.
We specifically wanted to understand what additional roles people think pharma companies can play - beyond developing and delivering innovative medicines.
People shared rich and varied feedback in our two surveys – that were open to the general public and to the patient and healthcare professional communities.
These findings are presented on this website in our European report, analyzing patients' and professionals’ insights.
Why this initiative?
- We firmly believe we should always strive to do more to help support patients, beyond the provision of medicines, and work in partnership across healthcare to enable this.
- We want to openly share the feedback in this summary report and most importantly respond.
- We will do this through a series of dialogues, discussions and collaboration workshops across healthcare, to co-create new local patient and community programmes. Together we can make a difference.
We hope you find these insights of interest and look forward to progressing on this journey together.
